https://www.selleckchem.com/pr....oducts/Cyclopamine.h
The mean monetary value of the incremental benefits of genomic sequencing was estimated at AU$5890 (95% CI AU$5730-$6046). Implementation of genomic sequencing for MDs in Australia could translate to an annual cost-saving of up to AU$0.7 million. Genomic sequencing is cost-saving relative to traditional investigative approaches, while enabling more diagnoses to be made in a timely manner, offering substantial personal benefits to children and their families. Our findings support the prioritization of genomic sequencing for children
Like
Comment
Share
